National Cancer Institute Archives
Vanderbilt scientists to lead chronic disease research initiative in Vietnam
Oct. 6, 2016—Scientists in the Vanderbilt Epidemiology Center (VEC) and Vanderbilt-Ingram Cancer Center (VICC) have been awarded a grant to plan and develop a Regional Center of Research Excellence in non-communicable diseases in Vietnam.
VICC researchers to study reasons for high breast cancer incidence and mortality rates among African-American women
Jul. 6, 2016—A cancer research consortium headed by investigators at Vanderbilt-Ingram Cancer Center and two other institutions have received $12 million in federal funding to help determine why African-American women die at a higher rate and have more aggressive breast cancer than white women.
Investigators find clues to melanoma treatment resistance
Oct. 29, 2015—Nearly half of all patients with malignant melanoma, the most deadly form of skin cancer, have a mutation in the BRAF gene found in their tumors. Mutations in the BRAF gene turn on a cancer growth switch known as the MAP kinase pathway.
Strong scores put VICC among top NCI centers
Sep. 17, 2015—Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG).
Macara lands award to explore cancer cell behavior
Aug. 13, 2015—Vanderbilt’s Ian Macara, Ph.D., has won an Outstanding Investigator Award from the National Cancer Institute (NCI) — nearly $6.6 million over seven years — to support the “unusual potential” of his research, which seeks to understand and predict cancer cell “behavior.”
NCI’s national report shows cancer deaths on decline in U.S.
Apr. 2, 2015—The death rates for most forms of cancer continue to decline at a modest pace among men, women and children in the United States, according to the Annual Report to the Nation on the Status of Cancer 1975 – 2011.
Photo: Cancer discoveries
Mar. 26, 2015—Louis Staudt, M.D., Ph.D., director of the National Cancer Institute (NCI) Center for Cancer Genomics and co-chief of the NCI’s Lymphoid Malignancies Branch, spoke about new lymphoma therapies at his recent Flexner Discovery Lecture.
National Cancer Institute’s Staudt set for Discovery Lecture
Mar. 12, 2015—Louis Staudt, M.D., Ph.D., a pioneer in gene expression profiling at the National Cancer Institute (NCI), will deliver the next Flexner Discovery Lecture on Thursday, March 19.
National Cancer Institute director set for Discovery Lecture
Nov. 14, 2013—The director of the National Cancer Institute, Harold Varmus, M.D., will deliver the next Flexner Discovery Lecture on Thursday, Nov. 21. His lecture, “New Directions in Cancer Research,” will begin at 4 p.m. in 208 Light Hall.
Vaccination key to preventing HPV-related cancers
Feb. 28, 2013—Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute.
Green tea found to reduce rate of some GI cancers
Oct. 31, 2012—Green tea may lower risk of some digestive cancers.
Folate may lower breast cancer risk for some
Sep. 29, 2011—Low folate levels may increase a premenopausal woman’s risk of developing breast cancer.
